Fuji Pharma (4554 JP)

FY9/2021 Investor Meeting

Speakers

• Takayuki Iwai (President & CEO, Fuji Pharma Co., Ltd.)
• Atsuya Mitsuhashi (Executive Corporate Officer, Head of Portfolio Management Department, Fuji Pharma Co., Ltd.)
• Masayuki Naganawa (Corporate Officer, Vice General Manager of Research & Development Division, Fuji Pharma Co., Ltd.)
• Takeshi Sato (Corporate Officer, General Manager of Corporate Planning Department, Fuji Pharma Co., Ltd.)

Duration

• Presentation: 16 minutes
• Q&A: 16 minutes

Q2 Financial Results Briefing for the Fiscal Year Ending September 2021

Speakers

• Takayuki Iwai (President & CEO, Fuji Pharma Co., Ltd.)
• Atsuya Mitsuhashi (Executive Corporate Officer, Head of Portfolio Management Department, Fuji Pharma Co., Ltd.)
• Masayuki Naganawa (Corporate Officer, Vice General Manager Research & Development Division, Fuji Pharma Co., Ltd.)
• Takeshi Sato (Corporate Officer, General Manager Corporate Planning Department, Fuji Pharma Co., Ltd.)